三明市药品限价采购政策效果研究

doi:10.5246/jcps.2018.11.080

中国药学(英文版) ›› 2018, Vol. 27 ›› Issue (11): 799-804.DOI: 10.5246/jcps.2018.11.080

• 【药事管理与临床药学专栏】 • 上一篇下一篇

三明市药品限价采购政策效果研究

尹婷, 江滨^*

北京大学医学部药学院药事管理与临床药学系, 北京 100191

收稿日期:2018-08-08 修回日期:2018-10-27 出版日期:2018-11-28 发布日期:2018-11-03
通讯作者: Tel.: +86-13601100121, E-mail: binjiang@bjmu.edu.cn
基金资助:
China Medical Board (Grant No. 15-221).

Effects of drug procurement under cap price policy in Sanming

Ting Yin, Bin Jiang^*

Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

Received:2018-08-08 Revised:2018-10-27 Online:2018-11-28 Published:2018-11-03
Contact: Tel.: +86-13601100121, E-mail: binjiang@bjmu.edu.cn
Supported by:
China Medical Board (Grant No. 15-221).

摘要/Abstract

摘要：

研究三明市药品限价采购政策的效果。通过对比福建省七八标和三明市第一次药品限价采购数据和实地调研,分析限价采购在品种、价格、供应、企业结构等方面的变化。结果发现: (1)限价采购后,采购品种和企业数量减少,品种和企业结构得到优化。(2)采购药品总体可以满足临床用药需求,但小部分药品存在断货现象。(3)药品价格总体下降,单价5元以上国产药品降幅约10%,进口药品降价少,单价低于3元的低价国产药品有一定涨幅。三明市药品限价采购政策在优化采购结构、控制“药价虚高”、完善产业结构等方面有明显成效,但也存在部分药品供应不足、进口原研药难降价等问题。

关键词: 药品限价采购, 药品招标, 政策效果, 三明

Abstract:

To study the effects of drug procurement under cap price policy (DPUCP) in Sanming, changes in drug category, price, availability and corporate structure were analyzed using purchasing data of the 7^th and 8^th centralized drug procurement in Fujian Province and the 1^st drug procurement under cap price in Sanming, and a field investigation was conducted. (1) The amounts of bid-winning drugs and pharmaceutical makers decreased sharply, leading to optimization of drug category and supplier structure. (2) The procurement could meet clinical demands, though a small percentage of drugs were out of stock. (3) Drug prices fell in general, with 10% decline in domestic drugs with a unit package price over RMB 5 yuan, a slight price reduction in imported drugs, and some price increase in cheap domestic drugs with a unit package price under RMB 3 yuan. DPUCP policy in Sanming optimized procurement drug category and supplier structure, reduced price, and improved industrial structure. However, problems still existed, such as shortage of some drugs and little price reduction in imported and brand-name drugs.

Key words: Drug procurement, Drug bidding, Policy effect, Sanming

中图分类号:

R951

Supporting:

尹婷, 江滨. 三明市药品限价采购政策效果研究[J]. 中国药学(英文版), 2018, 27(11): 799-804.

Ting Yin, Bin Jiang. Effects of drug procurement under cap price policy in Sanming[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(11): 799-804.

参考文献

[1] Sanming Leading Group for Deepening Healthcare Reform. 2013. This article can be found online at http://www.sm.gov.cn/fw/ggfwpt/ylws/zcfg/201403/t20140306_300775.htm.

[2] Chen, C.; Li, B.; Yang, D.S.; Jiang, B. Implementation of NFS (2012) in Qingdao: from the Perspective of Public Policy Implementation. Chin. Pharm. Sci. 2016, 25, 695–699.

[3] Gan, J.; Wang, S.L.; Deng, Z.G.; Pu, C. Effect, Existing Problems and Suggestions on the Implementation of Drug Purchasing System Based on the Investigation of Primary Medical and Health Institutions in Chongqing City. Chin. Pharm. 2016, 27, 2884–2886.

[4] Gao, C.S.; Shi, Y.P. The Impacts of Medicine Centralized Bidding and Purchasing Policy: An Empirical Study on the Relationship between the Bid Winners and the Bidden Prices. Chin. J. Health. Policy. 2015, 8, 7–13.

[5] Guo, J. The Research about the Quality and Price of the Drug Centralised Bid Procurement in Shanxi Province. MPH. Shanxi Medical University. 2010.

[6] Yang, Z.; Zhao, Y.; Chen, J.; Yu, J.X.; Lan, J.W.; Jiang, B. Investigating on the Effects of National Essential Medicine Policy on Primary Care Facilities in Hebei Province: A Case Study. Chin. Pharm. Sci. 2015, 24, 683–689.

[7] Hu, M.; Zeng, Y.; Yang, J.B.; Wu, P. A Survey of Drug Supply Organizations in Rural Areas in Four Provinces of China. Chin. Pharm. Sci. 2005, 14, 237–241.

[8] Wu, L.N.; Fang, Y.; Yang, C.J.; Shen, Q.; Chang, J.; Zhu, W.W.; Ye, D.; Lv, B.; Yang, S.A Review of Research on Drug Shortages in China. Chin. Pharm. Affa. 2016, 5, 458–465.

[9] Ma, J.C.; Luo, Z.W.; Liu, Z.L.; Chen, J.S. Survey on the Shortage of Drugs in Medical Institutions of Six Regions in China Chin. Hosp. Pharm. J. 2014, 34, 229–232.

[10] Fujian Provicial Medical Security Management Committee Office. 2017. This article can be found online at http://www.fjylbz.gov.cn/med/rest/med/postDetailed.htm? postId=c876c77b-5223-4f4f-9f4c-37125d6f391d&type= zwdwgk.

[11] Tang, X. Research on the Development Path of China’s Drug Procurement Model. MPA. Southwest University. 2015.

[12] Wu, S.H.; Wu, Q.Y. Frequent Drug Shortages Forcing Medical Price Reform. Chin. Pharms. 2016, 25, 1–3.

[13] Ying, Y.Z. Report on the Reform of Public Hospitals in Sanming City. Health. Econom. Res. 2014, 10, 30–33.

[14] Huang, J. Drug Price Management and Countermeasures in China since the New Medical Reform. MPA. Fudan University. 2014.

[15] Huang, X.W.; Lv, Y.L.; Shi, L.W.; Jiang, B. Exploratory research on drug safety in China. Chin. Pharm. Sci. 2009, 18, 278–282.

[16] Yu, S.S.; Zhang, Z.F.; Li, Z.Q. Investigation and Countermeasures to the Current Status of the Generics Quality Consistency Evaluation. Chin. J. Clin. Pharm. Therap. 2015, 20, 118–120.

三明市药品限价采购政策效果研究

Effects of drug procurement under cap price policy in Sanming

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	于爱晨, 傅孟元, 倪冰玉, 满春霞, 张婧媛, 胡华杰, 田野, 周越, 韩晟, 管晓东, 史录文. 2011–2017年三明市县级公立医院医生药品使用趋势研究[J]. 中国药学(英文版), 2022, 31(3): 218-223.
[2]	周若婧, 江滨. 福建省药品联合限价阳光采购政策效果评估[J]. 中国药学(英文版), 2020, 29(2): 139-152.
[3]	杨照, 赵宜乐, 陈璟, 于嘉轩, 兰建闻, 江滨. 中国基本药物制度实施效果评价—以河北省为例[J]. 中国药学(英文版), 2015, 24(10): 683-689.